drugset / Trial / NCT06663332
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Non-randomizedParallel-groupOpen-labelOther
Summary
The purpose of this study is to evaluate long-term safety of subcutaneous guselkumab in pediatric participants with moderately to severely active ulcerative colitis, or moderately to severely active Crohn's disease, or juvenile psoriatic arthritis (jPsA).
Timeline
- Start
- 2024-10-29
- Primary completion
- 2031-12-12
- Completion
- 2032-02-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Guselkumab | Monoclonal antibody | — | Subcutaneous |